Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-035177

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cermak Elizabeth Director 2025-11-12 Grant or award · Stock Options (right to buy) +150,000 164,668 D: show line 1 in the form
Loading xslF345X05/rdgdoc.xml…